Report Detail

Chemical & Material Global Collagen and HA-Based Biomaterials Market Professional Survey Report 2019

  • RnM3743512
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Chemical & Material

Global Collagen and HA-Based Biomaterials Market Professional Survey Report 2019

Table of Contents

    Executive Summary

      1 Industry Overview of Collagen and HA-Based Biomaterials

      • 1.1 Definition of Collagen and HA-Based Biomaterials
      • 1.2 Collagen and HA-Based Biomaterials Segment by Type
        • 1.2.1 Global Collagen and HA-Based Biomaterials Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Urinary Incontinence
        • 1.2.3 Corneal Shields
        • 1.2.4 Facial Aesthetic Dermal Fillers
        • 1.2.5 Wound Dressings
        • 1.2.6 Others
      • 1.3 Collagen and HA-Based Biomaterials Segment by Applications
        • 1.3.1 Global Collagen and HA-Based Biomaterials Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Cosmetology
        • 1.3.3 Wound Care
        • 1.3.4 Others
      • 1.4 Global Collagen and HA-Based Biomaterials Overall Market
        • 1.4.1 Global Collagen and HA-Based Biomaterials Revenue (2014-2025)
        • 1.4.2 Global Collagen and HA-Based Biomaterials Production (2014-2025)
        • 1.4.3 North America Collagen and HA-Based Biomaterials Status and Prospect (2014-2025)
        • 1.4.4 Europe Collagen and HA-Based Biomaterials Status and Prospect (2014-2025)
        • 1.4.5 China Collagen and HA-Based Biomaterials Status and Prospect (2014-2025)
        • 1.4.6 Japan Collagen and HA-Based Biomaterials Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Collagen and HA-Based Biomaterials Status and Prospect (2014-2025)
        • 1.4.8 India Collagen and HA-Based Biomaterials Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Collagen and HA-Based Biomaterials
      • 2.3 Manufacturing Process Analysis of Collagen and HA-Based Biomaterials
      • 2.4 Industry Chain Structure of Collagen and HA-Based Biomaterials

      3 Development and Manufacturing Plants Analysis of Collagen and HA-Based Biomaterials

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Collagen and HA-Based Biomaterials Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Collagen and HA-Based Biomaterials
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Collagen and HA-Based Biomaterials Production and Capacity Analysis
      • 4.2 Collagen and HA-Based Biomaterials Revenue Analysis
      • 4.3 Collagen and HA-Based Biomaterials Price Analysis
      • 4.4 Market Concentration Degree

      5 Collagen and HA-Based Biomaterials Regional Market Analysis

      • 5.1 Collagen and HA-Based Biomaterials Production by Regions
        • 5.1.1 Global Collagen and HA-Based Biomaterials Production by Regions
        • 5.1.2 Global Collagen and HA-Based Biomaterials Revenue by Regions
      • 5.2 Collagen and HA-Based Biomaterials Consumption by Regions
      • 5.3 North America Collagen and HA-Based Biomaterials Market Analysis
        • 5.3.1 North America Collagen and HA-Based Biomaterials Production
        • 5.3.2 North America Collagen and HA-Based Biomaterials Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Collagen and HA-Based Biomaterials Import and Export
      • 5.4 Europe Collagen and HA-Based Biomaterials Market Analysis
        • 5.4.1 Europe Collagen and HA-Based Biomaterials Production
        • 5.4.2 Europe Collagen and HA-Based Biomaterials Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Collagen and HA-Based Biomaterials Import and Export
      • 5.5 China Collagen and HA-Based Biomaterials Market Analysis
        • 5.5.1 China Collagen and HA-Based Biomaterials Production
        • 5.5.2 China Collagen and HA-Based Biomaterials Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Collagen and HA-Based Biomaterials Import and Export
      • 5.6 Japan Collagen and HA-Based Biomaterials Market Analysis
        • 5.6.1 Japan Collagen and HA-Based Biomaterials Production
        • 5.6.2 Japan Collagen and HA-Based Biomaterials Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Collagen and HA-Based Biomaterials Import and Export
      • 5.7 Southeast Asia Collagen and HA-Based Biomaterials Market Analysis
        • 5.7.1 Southeast Asia Collagen and HA-Based Biomaterials Production
        • 5.7.2 Southeast Asia Collagen and HA-Based Biomaterials Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Collagen and HA-Based Biomaterials Import and Export
      • 5.8 India Collagen and HA-Based Biomaterials Market Analysis
        • 5.8.1 India Collagen and HA-Based Biomaterials Production
        • 5.8.2 India Collagen and HA-Based Biomaterials Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Collagen and HA-Based Biomaterials Import and Export

      6 Collagen and HA-Based Biomaterials Segment Market Analysis (by Type)

      • 6.1 Global Collagen and HA-Based Biomaterials Production by Type
      • 6.2 Global Collagen and HA-Based Biomaterials Revenue by Type
      • 6.3 Collagen and HA-Based Biomaterials Price by Type

      7 Collagen and HA-Based Biomaterials Segment Market Analysis (by Application)

      • 7.1 Global Collagen and HA-Based Biomaterials Consumption by Application
      • 7.2 Global Collagen and HA-Based Biomaterials Consumption Market Share by Application (2014-2019)

      8 Collagen and HA-Based Biomaterials Major Manufacturers Analysis

      • 8.1 Abbott Medical Optics, Inc. (US)
        • 8.1.1 Abbott Medical Optics, Inc. (US) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.1.2 Abbott Medical Optics, Inc. (US) Product Introduction, Application and Specification
        • 8.1.3 Abbott Medical Optics, Inc. (US) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Alcon Laboratories, Inc. (US)
        • 8.2.1 Alcon Laboratories, Inc. (US) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.2.2 Alcon Laboratories, Inc. (US) Product Introduction, Application and Specification
        • 8.2.3 Alcon Laboratories, Inc. (US) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Allergan, Inc. (US)
        • 8.3.1 Allergan, Inc. (US) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.3.2 Allergan, Inc. (US) Product Introduction, Application and Specification
        • 8.3.3 Allergan, Inc. (US) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Anika Therapeutics, Inc. (US)
        • 8.4.1 Anika Therapeutics, Inc. (US) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.4.2 Anika Therapeutics, Inc. (US) Product Introduction, Application and Specification
        • 8.4.3 Anika Therapeutics, Inc. (US) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Bausch & Lomb, Inc. (US)
        • 8.5.1 Bausch & Lomb, Inc. (US) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.5.2 Bausch & Lomb, Inc. (US) Product Introduction, Application and Specification
        • 8.5.3 Bausch & Lomb, Inc. (US) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Collagen Solutions Plc. (UK)
        • 8.6.1 Collagen Solutions Plc. (UK) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.6.2 Collagen Solutions Plc. (UK) Product Introduction, Application and Specification
        • 8.6.3 Collagen Solutions Plc. (UK) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Galderma (Switzerland)
        • 8.7.1 Galderma (Switzerland) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.7.2 Galderma (Switzerland) Product Introduction, Application and Specification
        • 8.7.3 Galderma (Switzerland) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Genzyme (US)
        • 8.8.1 Genzyme (US) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.8.2 Genzyme (US) Product Introduction, Application and Specification
        • 8.8.3 Genzyme (US) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Lifecore Biomedical, LLC (US)
        • 8.9.1 Lifecore Biomedical, LLC (US) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.9.2 Lifecore Biomedical, LLC (US) Product Introduction, Application and Specification
        • 8.9.3 Lifecore Biomedical, LLC (US) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Seikagaku Corp. (Japan)
        • 8.10.1 Seikagaku Corp. (Japan) Collagen and HA-Based Biomaterials Production Sites and Area Served
        • 8.10.2 Seikagaku Corp. (Japan) Product Introduction, Application and Specification
        • 8.10.3 Seikagaku Corp. (Japan) Collagen and HA-Based Biomaterials Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Teijin Pharma Limited (Japan)

      9 Development Trend of Analysis of Collagen and HA-Based Biomaterials Market

      • 9.1 Global Collagen and HA-Based Biomaterials Market Trend Analysis
        • 9.1.1 Global Collagen and HA-Based Biomaterials Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Collagen and HA-Based Biomaterials Regional Market Trend
        • 9.2.1 North America Collagen and HA-Based Biomaterials Forecast 2019-2025
        • 9.2.2 Europe Collagen and HA-Based Biomaterials Forecast 2019-2025
        • 9.2.3 China Collagen and HA-Based Biomaterials Forecast 2019-2025
        • 9.2.4 Japan Collagen and HA-Based Biomaterials Forecast 2019-2025
        • 9.2.5 Southeast Asia Collagen and HA-Based Biomaterials Forecast 2019-2025
        • 9.2.6 India Collagen and HA-Based Biomaterials Forecast 2019-2025
      • 9.3 Collagen and HA-Based Biomaterials Market Trend (Product Type)
      • 9.4 Collagen and HA-Based Biomaterials Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Collagen and HA-Based Biomaterials Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A biomaterial is any substance that has been engineered to interact with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one. As a science, biomaterials is about fifty years old. Hyaluronic acid (HA) is a substance which is naturally present in the human body with highest concentration in the eye and joints. It has wide applications in the field of osteoarthritis, eye surgery, plastic surgery, prevention of aging etc.
        Geographically, North America holds a leading position with regards to collagen and HA-based biomaterials market followed by the European market. Some of the major factors responsible for the growth of this market in these regions are increasing prevalence of various diseases, development of new and technologically advanced products, use of single-injection visco supplement products, and increasing need of individuals to stay fit and healthy in their advancing years. Asia-Pacific is one of the most lucrative markets for the expansion of collagen and HA-based biomaterials. This region is growing and developing at a rapid pace. The prime reasons which will proliferate the growth of this market in the Asia-Pacific region are high market penetration, increasing demand for tissue regeneration in developing regions, increasing number of elderly people with chronic arthritis due to high population density in countries like China and India, increasing need of individuals to opt for anti-aging treatments in order to enhance their physical appearance, and rising disposable income of the people to spend on sophisticated and advanced technologies.

        The global Collagen and HA-Based Biomaterials market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Collagen and HA-Based Biomaterials volume and value at global level, regional level and company level. From a global perspective, this report represents overall Collagen and HA-Based Biomaterials market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Collagen and HA-Based Biomaterials in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Collagen and HA-Based Biomaterials manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Abbott Medical Optics, Inc. (US)
        Alcon Laboratories, Inc. (US)
        Allergan, Inc. (US)
        Anika Therapeutics, Inc. (US)
        Bausch & Lomb, Inc. (US)
        Collagen Solutions Plc. (UK)
        Galderma (Switzerland)
        Genzyme (US)
        Lifecore Biomedical, LLC (US)
        Seikagaku Corp. (Japan)
        Teijin Pharma Limited (Japan)

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Urinary Incontinence
        Corneal Shields
        Facial Aesthetic Dermal Fillers
        Wound Dressings
        Others

        Segment by Application
        Cosmetology
        Wound Care
        Others


        Summary:
        Get latest Market Research Reports on Collagen and HA-Based Biomaterials. Industry analysis & Market Report on Collagen and HA-Based Biomaterials is a syndicated market report, published as Global Collagen and HA-Based Biomaterials Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Collagen and HA-Based Biomaterials market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,802.38
        4,203.58
        5,604.77
        3,166.44
        4,749.66
        6,332.88
        378,084.00
        567,126.00
        756,168.00
        249,460.75
        374,191.13
        498,921.50
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report